Currently, fertility preservation is an important Topic in reproductive medicine. This Topic is also a principal issue among cancer survivors. Research advances have led to rapid development in the methods of fertility preservation. In particular, the development of ovarian tissue cryopreservation has had remarkable results. According to a recent paper on fertility preservation in women, approximately 130 live births using cryopreserved ovarian tissue have been reported. In fact, more than 4500 procedures of ovarian tissue cryopreservation were performed in Europe. However, this new method of fertility preservation is associated with the crucial issue of eliminating “minimal residual disease”. To remove malignant cells from the ovarian tissue is the next challenge to be addressed. Meanwhile, the technology of testicular tissue cryopreservation is still in early experimental stages. Hence, significant breakthroughs are needed, including in the bio engineering area, before these methods become established techniques.
In the present Research Topic, we focus on the progress of contemporary basic research on ovarian and testicular tissue cryopreservation. We also review improvements in controlled ovarian stimulation for viable embryos and oocyte cryopreservation, and the current status of fertility preservation in developing and Asian countries. The current status of fertility preservation in Europe has already been investigated by Anderson. However, for a comprehensive discussion of developments in fertility preservation, the current status in Asian countries also needs assessment. An investigation from the perspective of co-medical staff (including nursing staff, psychologists, and social welfare counselors) is also important. Our Research Topic will focus on this point as well as on instructional system for young medical staff and students.
Therefore, we will welcome researchers investigating advanced gonadal cryopreservation techniques to provide inputs regarding newly developed methods including in vitro follicle culture and artificial ovary. We will also welcome specialists in fertility preservation in female and male patients, as well as pediatric patients, to review the current status of fertility preservation. Co-medical researchers will also be welcomed to promote fertility preservation among medical staff. Finally, educational professionals will participate in this project for developing fertility preservation in society as a whole.
Currently, fertility preservation is an important Topic in reproductive medicine. This Topic is also a principal issue among cancer survivors. Research advances have led to rapid development in the methods of fertility preservation. In particular, the development of ovarian tissue cryopreservation has had remarkable results. According to a recent paper on fertility preservation in women, approximately 130 live births using cryopreserved ovarian tissue have been reported. In fact, more than 4500 procedures of ovarian tissue cryopreservation were performed in Europe. However, this new method of fertility preservation is associated with the crucial issue of eliminating “minimal residual disease”. To remove malignant cells from the ovarian tissue is the next challenge to be addressed. Meanwhile, the technology of testicular tissue cryopreservation is still in early experimental stages. Hence, significant breakthroughs are needed, including in the bio engineering area, before these methods become established techniques.
In the present Research Topic, we focus on the progress of contemporary basic research on ovarian and testicular tissue cryopreservation. We also review improvements in controlled ovarian stimulation for viable embryos and oocyte cryopreservation, and the current status of fertility preservation in developing and Asian countries. The current status of fertility preservation in Europe has already been investigated by Anderson. However, for a comprehensive discussion of developments in fertility preservation, the current status in Asian countries also needs assessment. An investigation from the perspective of co-medical staff (including nursing staff, psychologists, and social welfare counselors) is also important. Our Research Topic will focus on this point as well as on instructional system for young medical staff and students.
Therefore, we will welcome researchers investigating advanced gonadal cryopreservation techniques to provide inputs regarding newly developed methods including in vitro follicle culture and artificial ovary. We will also welcome specialists in fertility preservation in female and male patients, as well as pediatric patients, to review the current status of fertility preservation. Co-medical researchers will also be welcomed to promote fertility preservation among medical staff. Finally, educational professionals will participate in this project for developing fertility preservation in society as a whole.
